Inventor
IMHOF-JUNG SABINE
DE29 patents
⚠️ This page may combine multiple inventors who share the name “IMHOF-JUNG SABINE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
22 patentsUS9914776B2Mar 13, 2018
Bispecific T cell activating antigen binding molecules
HOFFMANN LA ROCHE16 citations92
US9708396B2Jul 18, 2017
Bispecific anti-VEGF/anti-ANG-2 antibodies
HOFFMANN LA ROCHE16 citations92
US10501521B2Dec 10, 2019
Disulfide-linked multivalent MHC class I comprising multi-function proteins
HOFFMANN LA ROCHE39 citations91
US11603411B2Mar 14, 2023
Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use
HOFFMANN LA ROCHE9 citations85
US10941205B2Mar 9, 2021
Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of use
HOFFMANN LA ROCHE10 citations85
US10611840B2Apr 7, 2020
Bispecific T cell activating antigen binding molecules
HOFFMANN LA ROCHE4 citations84
US10611841B2Apr 7, 2020
Bispecific T cell activating antigen binding molecules
HOFFMANN LA ROCHE4 citations84
US11285207B2Mar 29, 2022
Bispecific antibodies specifically binding to PD1 and LAG3
HOFFMANN LA ROCHE10 citations83
US11673945B2Jun 13, 2023
Bispecific antigen binding proteins
HOFFMANN LA ROCHE4 citations75
US11117965B2Sep 14, 2021
Bispecific T cell activating antigen binding molecules
HOFFMANN LA ROCHE2 citations73
US10640555B2May 5, 2020
Bispecific antigen binding proteins
HOFFMANN LA ROCHE2 citations73
US11787868B2Oct 17, 2023
Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of use
HOFFMANN LA ROCHE1 citations72
US10434184B2Oct 8, 2019
Anti-TPBG antibodies and methods of use
HOFFMANN LA ROCHE3 citations70
US12358997B1Jul 15, 2025
Bispecific anti-human A-beta/anti-human transferrin receptor antibodies
HOFFMANN LA ROCHE0 citations62
US12030952B2Jul 9, 2024
Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use
HOFFMANN LA ROCHE1 citations62
US10766967B2Sep 8, 2020
Bispecific T cell activating antigen binding molecules
HOFFMANN LA ROCHE1 citations62
US12227594B2Feb 18, 2025
Bispecific 2+1 contorsbodies
HOFFMANN LA ROCHE1 citations61
US11866490B2Jan 9, 2024
Antibody that binds to VEGF and IL-1beta and methods of use
HOFFMANN LA ROCHE0 citations60
US11130804B2Sep 28, 2021
Antibody that binds to VEGF and IL-1beta and methods of use
HOFFMANN LA ROCHE0 citations60
US12522653B2Jan 13, 2026
Antibody that binds to VEGF-A and ANG2 and methods of use
HOFFMANN LA ROCHE0 citations59
US11732036B2Aug 22, 2023
Antibody that binds to VEGF-A and ANG2 and methods of use
HOFFMANN LA ROCHE0 citations59
US11780919B2Oct 10, 2023
Bispecific antigen binding molecules targeting OX40 and FAP
HOFFMANN LA ROCHE1 citations56